De-Escalation Strategies in HPV-Associated Oropharynx Cancer—Are we Putting the Cart Before the Horse?
- 1 July 2019
- journal article
- research article
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 104 (4) , 705-709
Abstract
No abstract availableFunding Information
- National Medical Research Council (NMRC/CSA-INV/0027/2018)
- National Institutes of Health (U01 DE022939)
- National Institutes of Health (R01 CA174976)
- National Institutes of Health (U01 DE027637)
- National Institutes of Health (P50 DE026787)
- University of Wisconsin Carbone Cancer Center (P30 CA014520)
This publication has 20 references indexed in Scilit:
- Genetic Landscape of Human Papillomavirus–Associated Head and Neck Cancer and Comparison to Tobacco-Related TumorsJournal of Clinical Oncology, 2015
- Epidemiology of Human Papillomavirus–Positive Head and Neck Squamous Cell CarcinomaJournal of Clinical Oncology, 2015
- Panitumumab plus radiotherapy versus chemoradiotherapy in patients with unresected, locally advanced squamous-cell carcinoma of the head and neck (CONCERT-2): a randomised, controlled, open-label phase 2 trialThe Lancet Oncology, 2015
- Comprehensive genomic characterization of head and neck squamous cell carcinomasNature, 2015
- Randomized Phase III Trial of Concurrent Accelerated Radiation Plus Cisplatin With or Without Cetuximab for Stage III to IV Head and Neck Carcinoma: RTOG 0522Journal of Clinical Oncology, 2014
- Enhanced Radiation Sensitivity in HPV-Positive Head and Neck CancerCancer Research, 2013
- Deintensification Candidate Subgroups in Human Papillomavirus–Related Oropharyngeal Cancer According to Minimal Risk of Distant MetastasisJournal of Clinical Oncology, 2013
- Human Papillomavirus and Survival of Patients with Oropharyngeal CancerNew England Journal of Medicine, 2010
- Critical Impact of Radiotherapy Protocol Compliance and Quality in the Treatment of Advanced Head and Neck Cancer: Results From TROG 02.02Journal of Clinical Oncology, 2010
- Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and NeckNew England Journal of Medicine, 2006